| Mon, Feb 8, 2010 | | • | Alkermes Retains Neutral Rec
Zacks.com (Mon, Feb 8)
| | • | [video] Alkermes CEO Sounds Off
at CNBC (Mon, Feb 8)
| | Sat, Feb 6, 2010 | | • | New Star Analyst Rankings for Alkermes, Inc.
StarMine (Sat, Feb 6)
| | Fri, Feb 5, 2010 | | • | [$$] Russell 2000 Falls for Fourth Week in a Row
at The Wall Street Journal Online (Fri, Feb 5)
| | • | Biotech Stocks: Drug stocks fall; Alkermes rallies on upgrade
at MarketWatch (Fri, Feb 5)
| | • | Biotech Stocks: Drug stocks slip; Alkermes rallies on upgrade
at MarketWatch (Fri, Feb 5)
| | • | Lower Q3 Loss for Alkermes
Zacks.com (Fri, Feb 5)
| | • | Drug stocks dip; Alkermes jumps on upgrade
at MarketWatch (Fri, Feb 5)
| | • | Premarket roundup: PerkinElmer, NCR
AP (Fri, Feb 5)
| | • | Ahead of the Bell: Alkermes upgraded on 3Q results
AP (Fri, Feb 5)
| | • | Wall Street Breakfast: Must-Know News
at Seeking Alpha (Fri, Feb 5)
| | • | Alkermes upgraded by Jefferies & Co
Briefing.com (Fri, Feb 5)
| | Thu, Feb 4, 2010 | | • | Alkermes, Inc. F3Q10 (Qtr End 12/31/09) Earnings Call Transcript
at Seeking Alpha (Thu, Feb 4)
| | • | Alkermes reports 3Q loss, smaller than expected
AP (Thu, Feb 4)
| | • | UPDATE - Alkermes posts narrower-than-expected Q3 loss
at Reuters (Thu, Feb 4)
| | • | ALKERMES INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Thu, Feb 4)
| | • | Alkermes Reports Third Quarter Fiscal 2010 Financial Results
Business Wire (Thu, Feb 4)
| | • | Alkermes Testing its Version of Popular Schizophrenia Drug
at TheStreet.com (Thu, Feb 4)
| | • | Alkermes Testing Schizophrenia Drug
at TheStreet.com (Thu, Feb 4)
| | • | Alkermes Unveils Long-Acting Injectable Proprietary Platform for Treatment of Schizophrenia and Other CNS Disorders
Business Wire (Thu, Feb 4)
|
Add ALKS News to My Yahoo!:
 
| |
|
0.54% Nasdaq 
0.02 (0.17%) 
Headlines
